RECITALSLicense and Distribution Agreement • May 21st, 2007 • Samaritan Pharmaceuticals Inc • Services-commercial physical & biological research • Pennsylvania
THE SYMBOL “[****]” DENOTES PLACES WHERE CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (i) NOT MATERIAL, AND (ii) THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL LICENSE AND DISTRIBUTION AGREEMENTLicense and Distribution Agreement • June 17th, 2022 • Quoin Pharmaceuticals, Ltd. • Surgical & medical instruments & apparatus
This License and Distribution Agreement (this “Agreement”), dated as of June 14, 2022 (“Effective Date”), is by and between by and between Quoin Pharmaceuticals, Inc., a Delaware corporation located at 42127 Pleasant Forest Court, Ashburn, VA 20148 (“Quoin”) and WINHEALTH INVESTMENT (HK) LIMITED, a company incorporated under the laws of Hong Kong located at Unit 2512, 25/F., Seapower Tower, Concordia Plaza, No.1 Science Museum Road, Kowloon, Hong Kong (“DISTRIBUTOR”) (“Licensee”). Quoin and Licensee are sometimes referred to herein individually as a “Party,” and together as the “Parties.”
BACKGROUNDLicense and Distribution Agreement • April 20th, 2005 • Valera Pharmaceuticals Inc • Pharmaceutical preparations • New Jersey
EX-10.7 14 d232021dex107.htm LICENSING AGREEMENT - MICHAEL KORS TRADING SHANGHAI LIMITED CERTAIN PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST. OMITTED INFORMATION IS INDICATED BY AN ASTERIK (*) AND HAS BEEN...License and Distribution Agreement • May 5th, 2020 • New York
LICENSE AND DISTRIBUTION AGREEMENT made as of this 1st day of April 2011, by and between MICHAEL KORS, L.L.C., a limited liability company existing under and by virtue of the laws of the State of Delaware, with offices at 11 West 42nd Street, New York, NY, 10036, USA (“Licensor”) and Michael Kors Trading (Shanghai) Company Limited, a Chinese trading company with offices at 35/F Citic Square, Room 3527, No.1168 Nanjing West Road, Shanghai 200041, P.R.China (“Licensee”).
EX-10.1 2 dex101.htm LICENSE AND DISTRIBUTION AGREEMENT LICENSE AND DISTRIBUTION AGREEMENTLicense and Distribution Agreement • May 5th, 2020 • California
THIS LICENSE AND DISTRIBUTION AGREEMENT (the “Agreement”) is made and dated as of this 8th day of August, 2006 (the “Effective Date”) by and among BIOLASE Technology, Inc., a Delaware corporation (the “Company”) and Henry Schein, Inc., a Delaware corporation (the “Distributor”) with reference to the following facts:
TECHNOLOGY TRANSFER, LICENSE AND DISTRIBUTION AGREEMENT dated as of February 7, 2007 between FUELCELL ENERGY, INC. and POSCO POWERLicense and Distribution Agreement • February 8th, 2010 • Fuelcell Energy Inc • Miscellaneous electrical machinery, equipment & supplies • New York
THIS TECHNOLOGY TRANSFER, LICENSE AND DISTRIBUTION AGREEMENT (this “Agreement”) is made and entered into this 7th day of February, 2007, by and between FUELCELL ENERGY, INC., a Delaware corporation having a place of business at 3 Great Pasture Rd., Danbury, CT 06813, U.S.A. (“FCE”) and POSCO POWER, a Korean corporation having a place of business at Dacom Building 10 th Fl., 706-1 Yeoksam-dong, Kangnam-gu, Seoul 135-987, Korea (“POSCO Power”).
EXHIBIT 2.2 AMENDED AND RESTATED LICENSE AND DISTRIBUTION AGREEMENTLicense and Distribution Agreement • January 23rd, 2001 • Cypress Bioscience Inc • Biological products, (no disgnostic substances) • New York
AMENDMENT NUMBER 2 TO THE LICENSE AND DISTRIBUTION AGREEMENTLicense and Distribution Agreement • March 26th, 2013 • Gw Pharmaceuticals PLC • Pharmaceutical preparations
between GW PHARMA LIMITED (“GW”) having its registered office at Porton Down Science Park, Salisbury, Wiltshire SP4 0JQ and BAYER HEALTHCARE AG, Division Pharma, having its registered office at Bayerwerk, 51368 Leverkusen, Germany (“Bayer”)
AMENDMENT NUMBER 4 TO THE LICENSE AND DISTRIBUTION AGREEMENTLicense and Distribution Agreement • March 26th, 2013 • Gw Pharmaceuticals PLC • Pharmaceutical preparations
between GW PHARMA LIMITED (“GW”) having its registered office at Porton Down Science Park, Salisbury, Wiltshire SP4 0JQ and BAYER HEALTHCARE AG, Division Pharma, having its registered office at Bayerwerk, 51368 Leverkusen, Germany (“Bayer”)
EXHIBIT 10.1 SECOND AMENDED AND RESTATED LICENSE AND DISTRIBUTION AGREEMENT This Second Amended and Restated License and Distribution Agreement (the "AGREEMENT" or "ARDA II") is entered into as of March 1, 1999 by and between Mallinckrodt Inc., a...License and Distribution Agreement • May 22nd, 2000 • Molecular Biosystems Inc • In vitro & in vivo diagnostic substances
LICENSE AND DISTRIBUTION AGREEMENTLicense and Distribution Agreement • June 16th, 2015 • BioCardia, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS LICENSE AND DISTRIBUTION AGREEMENT (the “Agreement”) is effective as of October 30, 2012 (the “Effective Date”) by and between BIOMET BIOLOGICS, LLC, a corporation organized and existing under the laws of the State of Indiana, having a place of business at 56 East Bell Drive, Warsaw, Indiana 46582 (“Biomet”) and BIOCARDIA, INC., a Delaware corporation with its principal place of business at 125 Shoreway Road, Suite B, San Carlos, CA 94070 (“BioCardia”). BioCardia and Biomet may be referred to individually as a “Party” or collectively as the “Parties.”
LICENSE AND DISTRIBUTION AGREEMENT between CHIESI FARMACEUTICI S.p.A. and CORNERSTONE THERAPEUTICS INC. Dated May 6, 2009License and Distribution Agreement • June 26th, 2009 • Cornerstone Therapeutics Inc • Pharmaceutical preparations
This LICENSE AND DISTRIBUTION AGREEMENT (this “Agreement”) is made as of this 6th day of May, 2009 (the “Effective Date”) between Chiesi Farmaceutici S.p.A. a company incorporated under the laws of Italy, with its principal place of business at Via Palermo 26/A, 43100 Parma, Italy (“Chiesi”) and Cornerstone Therapeutics Inc. a corporation incorporated under the laws of Delaware, with its principal place of business at 1255 Crescent Green Drive, Suite 250, Cary, North Carolina 27518, USA (“Cornerstone”, and together with Chiesi, the “Parties”, each a “Party”).
Amendment No. 9 to the Master Software License and Distribution Agreement (Contract No. 220-00-0134) between Verizon Corporate Services Group Inc. and Smith Micro Software, Inc.License and Distribution Agreement • April 28th, 2010 • Smith Micro Software Inc • Services-prepackaged software
This Amendment No. 9 (“Amendment”) amends the Master Software License and Distribution Agreement (“Agreement”) between Verizon Corporate Services Group Inc., a New York corporation (“Verizon”) on behalf of itself and for the benefit of its Affiliates, and Smith Micro Software, Inc. (“SMSI”). This Amendment shall be effective as of October 30, 2009 (the “Effective Date”), unless terminated in accordance with the Agreement (Termination).
EX-4.25 2 dex425.htm XYREM LICENSE AND DISTRIBUTION AGREEMENT DATED AS OF OCTOBER 29 CONFIDENTIAL EXECUTION VERSIONLicense and Distribution Agreement • May 5th, 2020 • New York
* CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. REDACTED PORTIONS OF THIS EXHIBIT ARE MARKED BY AN * .
EX-10.37 2 dex1037.htm LICENSE AND DISTRIBUTION AGREEMENT Pursuant to 17 CFR 240.24b-2, confidential information has been omitted in places marked “[* * *]” and has been filed separately with the Securities and Exchange Commission pursuant to a...License and Distribution Agreement • May 5th, 2020 • Massachusetts
This License and Distribution Agreement (this “Agreement”) made as of the 29th day of July, 2003 by and between Keurig, Incorporated, a Delaware corporation with its principal executive offices located at 101 Edgewater Drive, Wakefield, Massachusetts 01880 (“Keurig”), and Diedrich Coffee, Inc., a Delaware corporation with its principal executive offices located at 2144 Michelson Drive, Irvine, CA 92612 (“Diedrich”) Diedrich amends and restates the License Agreement between Keurig and Diedrich dated as of March 13, 2000.
EXHIBIT 10.12 CERTAIN PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT UNDER RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934. THE OMITTED MATERIALS HAVE BEEN FILED SEPARATELY WITH THE SECURITIES AND...License and Distribution Agreement • March 31st, 2005 • Radview Software LTD • Services-prepackaged software • Delaware
1 EXHIBIT 10.3 LICENSE AND DISTRIBUTION AGREEMENT Agreement made as of February 5, 1996 by and between DSL Entertainment Group, Inc., ("Producer"), with offices at 12300 Wilshire Blvd. Suite 400, Los Angeles, California 90025 and Allied Communications...License and Distribution Agreement • October 14th, 1997 • Team Communication Group Inc • Services-motion picture & video tape distribution • California
Exhibit 10.11 FREEHAND SYSTEMS, INC. LICENSE AND DISTRIBUTION AGREEMENT Agreement is entered into this 1st 3th day of November, 2006, by and between FreeHand Systems, Inc., a Nevada corporation ("Freehand"), 95 First Street, Suite 200, Los Altos, CA...License and Distribution Agreement • August 29th, 2007 • Freehand Information Systems, Inc. • Blank checks • California
11th AMENDMENT TO THE 2nd RENEWAL OF RAGNAROK LICENSE AND DISTRIBUTION AGREEMENTLicense and Distribution Agreement • April 28th, 2022 • GRAVITY Co., Ltd. • Services-business services, nec
THIS AMENDMENT (“Amendment”) is made and entered into on this 29th day September, 2021 (“Effective Date”) by and between Gravity Co., Ltd., a corporation duly organized and existing under the laws of the Republic of Korea (hereinafter referred to as “Korea”) and having its principle office at 15F Nuritkum Square R&D Tower, Worldcup Bukro 396, Mapo-Gu, Seoul, 03925, Korea (“Licensor”) and GungHo Online Entertainment, Inc., a corporation duly organized and existing under the laws of Japan and having its principal office at 1-11-1 Marunouchi, Chiyoda-ku, Tokyo, 100-6221 Japan (“Licensee”).
AMENDMENT NUMBER 3 TO THE LICENSE AND DISTRIBUTION AGREEMENTLicense and Distribution Agreement • March 26th, 2013 • Gw Pharmaceuticals PLC • Pharmaceutical preparations
between GW PHARMA LIMITED (“GW”) having its registered office at Porton Down Science Park, Salisbury, Wiltshire SP4 OJQ and BAYER HEALTHCARE AG, Division Pharma, having its registered office at Bayerwerk, 51368 Leverkusen, Germany (“Bayer”)
LICENSE AND DISTRIBUTION AGREEMENTLicense and Distribution Agreement • June 14th, 2004 • Archipelago Holdings L L C • Security & commodity brokers, dealers, exchanges & services • Illinois
AGREEMENT, dated as of January 7, 1999 (the “Effective Date”), by and between ARCHIPELAGO HOLDINGS, L.L.C., a Delaware limited liability company with its principal offices at 100 South Wacker Drive, Suite 2060, Chicago, IL 60606 (“Archipelago”), and TOWNSEND ANALYTICS, LTD., an Illinois corporation with its principal offices at 100 South Wacker Drive, Suite 2040, Chicago, Illinois 60606 (“TAL”).
BAYER AG and GW PHARMA LTD LICENSE AND DISTRIBUTION AGREEMENTLicense and Distribution Agreement • March 26th, 2013 • Gw Pharmaceuticals PLC • Pharmaceutical preparations
THIS LICENSE AND DISTRIBUTION AGREEMENT (hereinafter “Agreement”), is made as of the 20th day of May 2003, between GW PHARMA LIMITED (“GW”) having its registered office at Porton Down Science Park, Salisbury, Wiltshire SP4 0JQ and BAYER AG, Bayer HealthCare, Division Pharma, having its registered office at Bayerwerk, 51368 Leverkusen, Germany (“Bayer”).
LICENSE AND DISTRIBUTION AGREEMENTLicense and Distribution Agreement • July 2nd, 2004 • Auxilium Pharmaceuticals Inc • Pharmaceutical preparations
THIS LICENSE AND DISTRIBUTION AGREEMENT (the “Agreement”), effective as of March 26, 2004 (the “Effective Date”) is entered into by and between Auxilium Pharmaceuticals, Inc. (“Auxilium”), a company incorporated under the laws of Delaware with offices at 160 W. Germantown Pike, Norristown, PA 19401, USA, and Ipsen Farmaceutica B.V. (“Ipsen”), a company incorporated under the laws of The Netherlands having a registered office at Hoofdweg Oostzijde 620, NL-2132 MJ Hoofddorp.
LICENSE AND DISTRIBUTION AGREEMENT THIS AGREEMENT made as of the 19th day of July, 1999 BETWEEN:License and Distribution Agreement • November 12th, 2004 • AccelRate Power Systems Inc. • British Columbia
Petrovic is the legal and beneficial owner of all right, title and interest in and to the Invention, the Patents, the Technology and the Petrovic Marks;
LICENSE AND DISTRIBUTION AGREEMENT Between WEBZEN INC. and NHN USA INC.License and Distribution Agreement • November 20th, 2009 • Webzen Inc • Services-business services, nec
This LICENSE AND DISTRIBUTION AGREEMENT (“Agreement”) is entered into this May 19, 2008 (hereinafter referred to as “Execution Date”) by and between WEBZEN Inc., a corporation duly organized and existing under the laws of the Republic of Korea (“Korea”) and having its principle office at 6F Daelim Acrotel, 467-6 Dogok-Dong, Kangnam-Gu, Seoul 135-971, Korea (hereinafter referred to as “WEBZEN” or “Licensor”), and NHN USA Inc., organized and existing under the laws of the State of Delaware, USA and having its registered office at 3353 Michelson Dr. Suite 250, Irvine, California 92612, USA (hereinafter referred to as “Licensee”). WEBZEN and Licensee are hereinafter referred individually as a “Party” and collectively as the “Parties”.
AMENDMENT NUMBER 1 TO THE LICENSE AND DISTRIBUTION AGREEMENTLicense and Distribution Agreement • March 26th, 2013 • Gw Pharmaceuticals PLC • Pharmaceutical preparations
between GW PHARMA LIMITED (“GW”) having its registered office at Porton Down Science Park, Salisbury, Wiltshire SP4 0JQ and BAYER HEALTHCARE AG, Division Pharma, having its registered office at Bayerwerk, 51368 Leverkusen, Germany (“Bayer”)
LICENSE AND DISTRIBUTION AGREEMENTLicense and Distribution Agreement • January 10th, 2024 • NovaBay Pharmaceuticals, Inc. • Pharmaceutical preparations • Colorado
This License and Distribution Agreement (this “Agreement”) is made and entered into as of January 5, 2024, by and between NovaBay Pharmaceuticals, Inc., a Delaware corporation having a principal place of business located at 2000 Powell Street, Suite 1150, Emeryville, California 94608 (“Licensor”), and Sonoma Pharmaceuticals, Inc., a Delaware corporation having a place of business at 5445 Conestoga Court, Unit 150, Boulder, Colorado 80301 (“Licensee”), and (collectively, the “Parties,” or each, individually, a “Party”).
LICENSE AND DISTRIBUTION AGREEMENTLicense and Distribution Agreement • August 14th, 2007 • Document Security Systems Inc • Services-computer integrated systems design • New York
This License and Distribution Agreement (this “Agreement”) is entered into as of this 27th day of June, 2007 (the “Effective Date”) by and between Document Security Systems, Inc., a corporation organized and existing under the laws of the State of New York (“DSS”), and Cultura Interactiva S.A. de C.V., a company organized and existing under the laws of Mexico (“Licensee”).
Exhibit 10.45 CONFIDENTIAL TREATMENT REQUESTED LICENSE AND DISTRIBUTION AGREEMENT Parties: Electronics for Imaging, Inc. ("EFI") a Delaware corporation 303 Velocity Way Foster City, California 94404 Axeda Systems Operating Company Inc. ("Axeda") a...License and Distribution Agreement • November 8th, 2002 • Axeda Systems Inc • Services-prepackaged software • California
LICENSE AND DISTRIBUTION AGREEMENT between MEDIFOCUS INC and MEDIFOCUS HOLDING LIMITED (BVI)License and Distribution Agreement • September 17th, 2014 • Medifocus Inc. • Surgical & medical instruments & apparatus • Maryland
This LICENSE AND DISTRIBUTION AGREEMENT is effective as of the 8th day of November 2013, by and between MEDIFOCUS INC, an Ontario, Canada corporation having a principal place of business at 10240 Old Columbia Road Suite G Columbia, Maryland U.S.A. 21046 (“Medifocus”), and Medifocus Holding Limited, a Company incorporated in the British Virgin Islands, having a registered address at Akara Building, 24 De Castro Street, Wickhams Cay 1, Road Town, Tortola, British Virgin Islands (“JV”).
ContractLicense and Distribution Agreement • May 5th, 2020
EX-10.9 12 ex10_9.htm EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENT FOR TIROSINT BETWEEN IBSA AND ALPHARMA PHARMACEUTICALS LLC DATED AUGUST 16, 2007
Sixth Amendment To The Exclusive RAGNAROK Online License and Distribution AgreementLicense and Distribution Agreement • June 27th, 2008 • GRAVITY Co., Ltd. • Services-business services, nec
THIS Sixth AMENDMENT (this “Amendment”) is made and entered into on this 27th day of February, 2008(hereinafter referred to as “Effective Date”), by and between Gravity Co., Ltd (hereinafter referred to as “Licensor”), PT. LYTO DATARINDO FORTUNA (hereinafter referred to as “Licensee”).
License and Distribution AgreementLicense and Distribution Agreement • July 17th, 2014 • Dutch Gold Resources Inc • Wholesale-chemicals & allied products • Nevada
This License Agreement (this "Agreement") is made effective as of June 27, 2014 between Dutch Gold Resources, Inc., of 3344 Peachtree Road, Atlanta, Georgia 30326 and Abba Medix Corporation of 1773 Bayly Street Pickering, Ontario, Canada L1W 2Y7.
AMENDMENT NUMBER 4 TO LICENSE AND DISTRIBUTION AGREEMENTLicense and Distribution Agreement • March 16th, 2007 • Altiris Inc • Services-prepackaged software
This Amendment Number 4 to the License and Distribution Agreement (the “Amendment”), dated September 27, 2006 (the “Effective Date”), amends the terms of the License and Distribution Agreement, dated August 2001, including any and all previous amendments thereto (the “Agreement”) by and between Altiris Inc., a Delaware corporation having its principal of place of business at 588 West 400 South, Lindon, Utah 84042 (“Altiris”) and Hewlett-Packard, a Delaware corporation having its principal place of business at 3000 Hanover Street, Palo Alto, California 94304 (“HP”) (individually, the “Party,” collectively, the “Parties”). Unless specifically modified or changed herein, the terms and conditions of the Agreement shall remain in effect. In the event of a conflict or inconsistency between the terms and conditions contained in this Amendment and the Agreement, the terms and conditions contained in this Amendment shall prevail.
LICENSE AND DISTRIBUTION AGREEMENTLicense and Distribution Agreement • August 5th, 2004 • Archipelago Holdings L L C • Security & commodity brokers, dealers, exchanges & services • Illinois
TOWNSEND ANALYTICS, LTD., an Illinois corporation (“TAL”), hereby grants to Wave Securities, L.L.C., a professional subscriber pursuant to applicable exchange requirements in effect from time to time (“Subscriber”), and Subscriber hereby agrees to and accepts from TAL, a personal, non-exclusive, non-transferable license (i) to use the machine readable version of the software selected by Subscriber as identified in Schedule A attached hereto and any corresponding user manual(s) or other user documentation (collectively, the “Licensed Product”); (ii) to use the Licensed Product to receive, access and/or display over Subscriber’s computer and/or equipment, fixed or portable, the market information consisting of securities and commodity prices, other information and other data (collectively “TAL DataÔ“) that is provided by stock exchanges, commodity exchanges, news and other information sources (collectively “Sources”), which includes, but is not limited to, those Sources selected by Subsc
